These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 11592371

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation.
    Milner JM, Rowan AD, Elliott SF, Cawston TE.
    Arthritis Rheum; 2003 Apr; 48(4):1057-66. PubMed ID: 12687549
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, van Wart H, Poole AR.
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [Abstract] [Full Text] [Related]

  • 5. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
    Cawston TE, Curry VA, Summers CA, Clark IM, Riley GP, Life PF, Spaull JR, Goldring MB, Koshy PJ, Rowan AD, Shingleton WD.
    Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
    [Abstract] [Full Text] [Related]

  • 6. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM, Rowan AD, Cawston TE, Young DA.
    Arthritis Res Ther; 2006 Oct; 8(5):R142. PubMed ID: 16919164
    [Abstract] [Full Text] [Related]

  • 7. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
    Price JS, Wang-Weigand S, Bohne R, Kozaci LD, Hollander AP.
    Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture.
    Cawston TE, Ellis AJ, Humm G, Lean E, Ward D, Curry V.
    Biochem Biophys Res Commun; 1995 Oct 04; 215(1):377-85. PubMed ID: 7575616
    [Abstract] [Full Text] [Related]

  • 9. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes.
    Shingleton WD, Jones D, Xu X, Cawston TE, Rowan AD.
    Rheumatology (Oxford); 2006 Aug 04; 45(8):958-65. PubMed ID: 16467367
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases.
    Morgan TG, Rowan AD, Dickinson SC, Jones D, Hollander AP, Deehan D, Cawston TE.
    Ann Rheum Dis; 2006 Feb 04; 65(2):184-90. PubMed ID: 15975972
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
    Barksby HE, Milner JM, Patterson AM, Peake NJ, Hui W, Robson T, Lakey R, Middleton J, Cawston TE, Richards CD, Rowan AD.
    Arthritis Rheum; 2006 Oct 04; 54(10):3244-53. PubMed ID: 17009259
    [Abstract] [Full Text] [Related]

  • 14. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
    Hui W, Rowan AD, Richards CD, Cawston TE.
    Arthritis Rheum; 2003 Dec 04; 48(12):3404-18. PubMed ID: 14673992
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.
    Hui W, Rowan AD, Cawston T.
    Ann Rheum Dis; 2001 Mar 04; 60(3):254-61. PubMed ID: 11171688
    [Abstract] [Full Text] [Related]

  • 16. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
    Patwari P, Cook MN, DiMicco MA, Blake SM, James IE, Kumar S, Cole AA, Lark MW, Grodzinsky AJ.
    Arthritis Rheum; 2003 May 04; 48(5):1292-301. PubMed ID: 12746902
    [Abstract] [Full Text] [Related]

  • 17. Sulfasalazine blocks the release of proteoglycan and collagen from cytokine stimulated cartilage and down-regulates metalloproteinases.
    Lakey RL, Cawston TE.
    Rheumatology (Oxford); 2009 Oct 04; 48(10):1208-12. PubMed ID: 19690126
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.
    Rowan AD, Koshy PJ, Shingleton WD, Degnan BA, Heath JK, Vernallis AB, Spaull JR, Life PF, Hudson K, Cawston TE.
    Arthritis Rheum; 2001 Jul 04; 44(7):1620-32. PubMed ID: 11465713
    [Abstract] [Full Text] [Related]

  • 19. A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to proinflammatory cytokines.
    Bryson H, Bunning RA, Feltell R, Kam CM, Kerrigan J, Powers JC, Buttle DJ.
    Arch Biochem Biophys; 1998 Jul 01; 355(1):15-25. PubMed ID: 9647662
    [Abstract] [Full Text] [Related]

  • 20. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT, Smith MM, Smith SM, Jackson CJ, Xue M, Little CB.
    Arthritis Rheum; 2009 Mar 01; 60(3):780-91. PubMed ID: 19248107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.